Updated 01/14/2022
RCAM Pauses Its COVID-19 Vaccination Efforts
Due to the increase in COVID-19 cases, RCAM is unable to staff any new COVID-19 Vaccination Clinics. We therefore have suspended giving any more COVID-19 vaccine.
We still enthusiastically endorse all eligible children to be protected from COVID-19.
See below for other options for getting your child their COVID vaccination.
Other Options for COVID Vaccination
uVax.oneTM describes itself as "a one-stop digital platform that connects patient with COVID-19 vaccination sites." It organizes information about where you can get your COVID vaccine and pairs you with the ones closest to you.
- Register a new account and schedule with uVax.one here.
- If you already have an account, you can log in here.
CDC - information about COVID-19 vaccination sites at vaccines.gov.
UNC Healthcare - information about COVID-19 vaccination sites here.
Health Park Pharmacy - we have gotten feedback from patients that Health Park Pharmacy offers COVID-19 vaccination. Also, multiple have reported to us that Health Park does a good job with giving the vaccine to children.
Who Needs a COVID Vaccine Booster?
Here the CDC website summarizes COVID Vaccine Booster recommendations.
As of January 5, 2022, booster doses have been recommended for children 12 years old and up.
11-02-2021
The ACIP has Recommended COVID Vaccine for Children 5 to 11 years old.
Most pediatricians follow the recommendation of the CDC's Advisory Committee on Immunization Practices (ACIP) about who should get vaccine.
That committee met Tuesday, November 2, 2021 and voted overwhelmingly to recommend COVID vaccine for children ages 5 to 11 years old.
In a related note, RCAM Also Recommends COVID Vaccine for Children 5 to 11 Years Old
The pediatricians at RCAM (as well as pediatricians pretty much every where else) enthusiastically endorse this new recommendation for the COVID vaccine.
10-29-2021
FDA Grants EUA for COVID Vaccine for Children 5 to 11 years old
On Friday, October 29, 2021, the US Food and Drug Administration (FDA) granted emergency use authorization (EUA) for the Pfizer COVID-19 vaccine for patients aged 5 to 11 years old.
The American Academy of Pediatrics has summarized information about this new recommendation here.
